The early innings of the obesity landscape is starting to take shape, and it seems to be forming similar patterns...
Read NowModular Medical (MODD) announced the 510(k) submission of their MODD1 insulin pump to the FDA last week. On average, the FDA takes approximately...
PremiumEducation - One of the primary reasons that private companies go public is to lower the cost and increase the efficiency of raising additional capital. However, investors who are not … Continue Reading
Read nowRecap - Healthcare stocks were routed early this week, falling 10% (based on the NASDAQ Biotech Index) before a bounce from mid-week into Friday. The similarities to … Continue Reading
Read nowInsights - Top-line results from Ohr Pharmaceuticals’ (OHRP) phase II IMPACT study, testing its squalamine eyedrops in age-related macular degeneration (wet-AMD), had a crushing effect on the stock Friday. … Continue Reading
Read nowEducation - Raising capital often carries positive implications for a company’s shareholders, enabling growth & acquisitions, for example, and may be accretive in the long run. But financings … Continue Reading
Read nowResearch - Our suggestion to take profits on some of our bigger winners late last week was well-timed. From the blow-off top (temporarily, at least) on Friday … Continue Reading
Read nowEducation - All companies, foreign and domestic, are required to file registration statements, periodic reports, and certain other forms disclosing material information to investors electronically through the SEC’s EDGAR portal. … Continue Reading
Read nowInsights - VBL Therapeutics (VBLT) claimed success in a trial of lead drug candidate VB-111 in brain cancer on Wednesday, sending the stock higher by 40% in early trading.
Read now
